1A28 | B:683-931; A:682-932 | HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN |
1A52 | A:306-544; B:305-544 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL |
1BSX | A:211-461; B:211-461 | STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS |
1DB1 | A:120-423 | CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D |
1E3G | A:669-918 | HUMAN ANDROGEN RECEPTOR LIGAND BINDING IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881) |
1E3K | B:683-931; A:682-932 | HUMAN PROGESTERON RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881) |
1ERE | A:305-548; B:305-548; C:305-548; D:305-548; E:305-548; F:305-548 | HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL |
1ERR | A:307-547; B:306-551 | HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE |
1EXA | A:182-417 | ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE ACTIVE R-ENANTIOMER BMS270394. |
1EXX | A:182-417 | ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE INACTIVE S-ENANTIOMER BMS270395. |
1FBY | A:224-458; B:1229-1458 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO 9-CIS RETINOIC ACID |
1FCX | A:183-417 | ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID BMS184394 |
1FCY | A:182-417 | ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564 |
1FCZ | A:183-417 | ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156 |
1FD0 | A:183-417 | ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254 |
1FM6 | A:227-458; U:227-458; D:206-477; X:206-477 | THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. |
1FM9 | A:227-458; D:206-477 | THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. |
1G1U | B:231-459; D:231-459; A:231-458; C:231-456 | THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND |
1G50 | C:2304-2547; B:1304-1549; A:304-550 | CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION |
1G5Y | B:231-459; D:231-459; A:231-458; C:231-456 | THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. |
1GS4 | A:670-917 | STRUCTURAL BASIS FOR THE GLUCOCORTICOID RESPONSE IN A MUTANT HUMAN ANDROGEN RECEPTOR (ARCCR) DERIVED FROM AN ANDROGEN-INDEPENDENT PROSTATE CANCER |
1GWQ | B:301-548; A:301-548 | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE |
1GWR | B:305-548; A:306-549 | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE |
1GWX | A:207-477; B:207-477 | MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS |
1I7G | A:199-468 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242 |
1I7I | A:207-476; B:207-473 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242 |
1IE8 | A:120-423 | CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO KH1060 |
1IE9 | A:118-423 | CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO MC1288 |
1ILG | A:142-431 | CRYSTAL STRUCTURE OF APO HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN |
1ILH | A:142-431 | CRYSTAL STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TO SR12813 |
1K74 | A:227-458; D:206-477 | THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES. |
1K7L | A:202-468; C:202-468; E:202-468; G:202-468 | THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE. |
1KKQ | A:200-468; B:200-468; C:200-468; D:200-468 | CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF |
1KNU | B:207-475; A:204-476 | LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST |
1KV6 | A:235-456; B:235-456 | X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ERR3 LIGAND-BINDING DOMAIN IN THE CONSTITUTIVELY ACTIVE CONFORMATION |
1L2I | A:305-547; B:305-547 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
1L2J | A:261-501; B:255-497 | HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R, R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL |
1LBD | A:225-462 | LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA |
1LV2 | A:99-327 | HEPATOCYTE NUCLEAR FACTOR 4 IS A TRANSCRIPTION FACTOR THAT CONSTITUTIVELY BINDS FATTY ACIDS |
1M13 | A:142-434 | CRYSTAL STRUCTURE OF THE HUMAN PREGANE X RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH HYPERFORIN, A CONSTITUENT OF ST. JOHN'S WORT |
1M2Z | D:525-777; A:523-777 | CRYSTAL STRUCTURE OF A DIMER COMPLEX OF THE HUMAN GLUCOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEXAMETHASONE AND A TIF2 COACTIVATOR MOTIF |
1MV9 | A:229-460 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE EICOSANOID DHA (DOCOSA HEXAENOIC ACID) AND A COACTIVATOR PEPTIDE |
1MVC | A:229-458 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE |
1MZN | A:227-458; E:2227-2458; C:1229-1458; G:3229-3458 | CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE |
1N46 | B:211-461; A:211-461 | CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC |
1N83 | A:261-511 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE ORPHAN NUCLEAR HORMONE RECEPTOR ROR(ALPHA)-LBD AND CHOLESTEROL |
1NAV | A:146-408 | THYROID RECEPTOR ALPHA IN COMPLEX WITH AN AGONIST SELECTIVE FOR THYROID RECEPTOR BETA1 |
1NAX | A:211-460 | THYROID RECEPTOR BETA1 IN COMPLEX WITH A BETA-SELECTIVE LIGAND |
1NDE | A:261-500 | ESTROGEN RECEPTOR BETA WITH SELECTIVE TRIAZINE MODULATOR |
1NHZ | A:530-776 | CRYSTAL STRUCTURE OF THE ANTAGONIST FORM OF GLUCOCORTICOID RECEPTOR |
1NQ0 | A:199-461 | TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD |
1NQ1 | A:199-461 | TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD |
1NQ2 | A:198-460 | TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING |
1NRL | B:142-431; A:142-433 | CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813 |
1NUO | A:201-460 | TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING |
1NYX | B:207-476; A:202-476 | LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST |
1OSH | A:245-475 | A CHEMICAL, GENETIC, AND STRUCTURAL ANALYSIS OF THE NUCLEAR BILE ACID RECEPTOR FXR |
1OVL | B:363-598; E:334-598; D:363-598; A:363-598; C:363-598; F:363-598 | CRYSTAL STRUCTURE OF NURR1 LBD |
1P8D | B:218-459; A:218-461 | X-RAY CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN WITH 24(S),25-EPOXYCHOLESTEROL |
1P93 | B:529-776; A:527-776; C:527-776; D:527-776 | CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR |
1PCG | B:304-547; A:304-547 | HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OF STEROID RECEPTOR-COACTIVATOR INTERACTIONS |
1PQ6 | B:220-460; A:220-460; D:220-460; C:220-438 | HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX |
1PQ9 | B:219-458; A:220-458; C:220-458; D:220-458 | HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX |
1PQC | B:219-458; A:220-458; C:220-458; D:220-458 | HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 |
1PRG | A:207-476; B:207-476 | LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA |
1PZL | A:137-369 | CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR SRC-1 PEPTIDE |
1Q4X | A:209-461 | CRYSTAL STRUCTURE OF HUMAN THYROID HORMONE RECEPTOR BETA LBD IN COMPLEX WITH SPECIFIC AGONIST GC-24 |
1QKM | A:260-500 | HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN |
1QKT | A:304-551 | MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL |
1QKU | B:304-550; C:304-550; A:301-550 | WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL |
1R5K | A:306-545; B:306-544; C:306-544 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH GW5638 |
1R6G | A:203-460 | CRYSTAL STRUCTURE OF THE THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BETA SELECTIVE COMPOUND |
1RDT | A:228-456; D:206-477 | CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER |
1S0X | A:261-511 | CRYSTAL STRUCTURE OF THE HUMAN RORALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH CHOLESTEROL SULFATE AT 2.2A |
1S0Z | A:120-423 | CRYSTAL STRUCTURE OF THE VDR LBD COMPLEXED TO SEOCALCITOL. |
1S19 | A:120-423 | CRYSTAL STRUCTURE OF VDR LIGAND BINDING DOMAIN COMPLEXED TO CALCIPOTRIOL. |
1SJ0 | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE ANTAGONIST LIGAND 4-D |
1SKX | A:143-431 | STRUCTURAL DISORDER IN THE COMPLEX OF HUMAN PXR AND THE MACROLIDE ANTIBIOTIC RIFAMPICIN |
1SQN | A:682-932; B:683-933 | PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN WITH BOUND NORETHINDRONE |
1SR7 | A:682-932; B:683-931 | PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUND MOMETASONE FUROATE |
1T5Z | A:669-918 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR ARA70 |
1T63 | A:669-918A | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3 |
1T65 | A:669-919 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON-HELICAL CONFORMATION |
1TFC | A:233-458; B:233-457 | CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE |
1TXI | A:120-423 | CRYSTAL STRUCTURE OF THE VDR LIGAND BINDING DOMAIN COMPLEXED TO TX522 |
1U3Q | B:261-497; A:263-497; C:263-497; D:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 |
1U3R | A:263-500; B:263-501 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338 |
1U3S | A:263-497; B:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797 |
1U9E | B:263-501; A:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 |
1UHL | A:298-528; B:206-445 | CRYSTAL STRUCTURE OF THE LXRALFA-RXRBETA LBD HETERODIMER |
1UOM | A:307-547 | THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND POTENT TETRAHYDROISOCHIOLIN LIGAND. |
1UPV | A:219-461 | CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST |
1UPW | A:219-461 | CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST |
1WM0 | X:200-477 | PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND |
1X76 | A:263-497; B:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
1X78 | A:263-500; B:263-500 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 |
1X7B | A:263-500; B:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 |
1X7E | A:305-549; B:305-549 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244 |
1X7J | A:263-497; B:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN |
1X7R | A:306-547 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN |
1XAP | A:175-409 | STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOIC ACID RECEPTOR BETA |
1XB7 | A:282-516 | X-RAY STRUCTURE OF ERRALPHA LBD IN COMPLEX WITH A PGC-1ALPHA PEPTIDE AT 2.5A RESOLUTION |
1XJ7 | A:663-918 | COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE |
1XLS | A:227-458; B:227-458; C:227-458; D:227-458; E:117-358; F:117-358; G:117-358; H:117-358 | CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS |
1XOW | A:671-919 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2-TERMINAL PEPTIDE, AR20-30, AND R1881 |
1XP1 | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15 |
1XP6 | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16 |
1XP9 | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18 |
1XPC | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19 |
1XQ3 | A:671-919 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH R1881 |
1XQC | A:307-548; C:307-548; B:307-548; D:307-548 | X-RAY STRUCTURE OF ERALPHA LBD BOUND TO A TETRAHYDROISOQUINOLINE SERM LIGAND AT 2.05A RESOLUTION |
1XV9 | A:227-458; C:227-458; B:103-348; D:103-348 | CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE. |
1XVP | C:227-462; A:227-458; B:103-348; D:103-348 | CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO |
1XZX | X:200-460 | THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS |
1Y0S | B:209-476; A:206-475 | CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331 |
1Y0X | X:199-460 | THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS |
1Y9R | A:737-983; B:737-984 | CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION |
1YA3 | A:737-982; C:737-982; B:738-982 | CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO PROGESTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION |
1YIM | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 4 |
1YIN | A:307-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 3F |
1YOK | A:300-538 | CRYSTAL STRUCTURE OF HUMAN LRH-1 BOUND WITH TIF-2 PEPTIDE AND PHOSPHATIDYLGLYCEROL |
1YOW | A:221-458 | HUMAN STEROIDOGENIC FACTOR 1 LBD WITH BOUND CO-FACTOR PEPTIDE |
1YUC | A:299-538; B:300-539 | HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO PHOSPHOLIPID AND A FRAGMENT OF HUMAN SHP |
1YY4 | A:263-497; B:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 1-CHLORO-6-(4-HYDROXY-PHENYL)-NAPHTHALEN-2-OL |
1YYE | A:263-500; B:263-496 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-202196 |
1Z95 | A:672-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN W741L MUTANT COMPLEX WITH R-BICALUTAMIDE |
1ZAF | A:263-500; B:263-500 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 3-BROMO-6-HYDROXY-2-(4-HYDROXY-PHENYL)-INDEN-1-ONE |
1ZDT | B:221-459; A:221-460 | THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1 |
1ZDU | A:253-492 | THE CRYSTAL STRUCTURE OF HUMAN LIVER RECEPTOR HOMOLOGUE-1 |
1ZEO | B:207-475; A:207-477 | CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH AN ALPHA-ARYLOXYPHENYLACETIC ACID AGONIST |
1ZGY | A:206-477 | STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP |
1ZKY | A:304-549; B:305-549 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-3M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
1ZUC | A:682-932; B:682-932 | PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE NONSTEROIDAL AGONIST TANAPROGET |
2A3I | A:732-984 | STRUCTURAL AND BIOCHEMICAL MECHANISMS FOR THE SPECIFICITY OF HORMONE BINDING AND COACTIVATOR ASSEMBLY BY MINERALOCORTICOID RECEPTOR |
2AA2 | A:727-983 | MINERALOCORTICOID RECEPTOR WITH BOUND ALDOSTERONE |
2AA5 | A:722-982; B:723-982 | MINERALOCORTICOID RECEPTOR WITH BOUND PROGESTERONE |
2AA6 | B:722-982; A:722-982 | MINERALOCORTICOID RECEPTOR S810L MUTANT WITH BOUND PROGESTERONE |
2AA7 | A:727-983 | MINERALOCORTICOID RECEPTOR WITH BOUND DEOXYCORTICOSTERONE |
2AAX | B:723-982; A:722-983 | MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND CORTISONE |
2AB2 | A:723-982; B:723-982 | MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND SPIRONOLACTONE |
2ABI | B:737-982; C:737-982; A:737-982 | CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE |
2ACL | C:225-458; A:225-457; E:225-457; G:225-457; B:202-443; D:202-443; F:202-443; H:202-445 | LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987 |
2AM9 | A:670-919 | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TESTOSTERONE |
2AMA | A:671-919 | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH DIHYDROTESTOSTERONE |
2AMB | A:671-919 | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TETRAHYDROGESTRINONE |
2AO6 | A:671-918 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881 |
2ATH | A:207-477; B:207-477 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IM COMPLEX WITH AN AGONIST |
2AWH | B:210-476; A:210-477 | HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 |
2AX6 | A:671-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH HYDROXYFLUTAMIDE |
2AX7 | A:672-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH S-1 |
2AX8 | A:672-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN W741L MUTANT IN COMPLEX WITH S-1 |
2AX9 | A:672-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH R-3 |
2AXA | A:672-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH S-1 |
2AYR | A:306-551 | A SERM DESIGNED FOR THE TREATMENT OF UTERINE LEIOMYOMA WITH UNIQUE TISSUE SPECIFICITY FOR UTERUS AND OVARIES IN RATS |
2B1V | B:305-549; A:305-548 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
2B1Z | B:305-547; A:305-548 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17METHYL-17ALPHA-DIHYDROEQUILENIN AND A GLUCOC INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
2B23 | B:305-547; A:305-548 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN AND A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
2B50 | A:211-476; B:205-475 | HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2 |
2BAW | B:211-477; A:211-475 | HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 |
2BJ4 | A:305-528; B:304-529 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST |
2E2R | A:232-459 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL A |
2EWP | A:233-456; B:233-456; C:234-456; D:235-455; E:237-455 | CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR-3 (ERR-GAMMA) LIGAND BINDING DOMAIND WITH TAMOXIFEN ANALOG GSK5182 |
2F4B | A:207-477; B:207-477 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH AN AGONIST |
2FAI | B:304-548; A:305-548 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-2M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
2FSZ | B:260-501; A:264-501 | A SECOND BINDING SITE FOR HYDROXYTAMOXIFEN WITHIN THE COACTIVATOR-BINDING GROOVE OF ESTROGEN RECEPTOR BETA |
2FVJ | A:207-477 | A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITS PPARG-COACTIVATOR-1 ALPHA (PGC1A) BUT POTENTIATES INSULIN SIGNALING IN VITRO |
2G0G | A:207-477; B:207-477 | STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES |
2G0H | A:207-477; B:207-477 | STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES |
2G44 | A:305-548; B:306-552 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M-G AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
2G5O | B:304-550; A:304-548 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 2-(BUT-1-ENYL)-17BETA-ESTRADIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
2GIU | A:260-500 | HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 45 |
2GL8 | D:11-228; C:11-227; B:11-226; A:11-224 | HUMAN RETINOIC ACID RECEPTOR RXR-GAMMA LIGAND-BINDING DOMAIN |
2GP7 | B:234-458; A:235-458; C:235-458; D:235-458 | ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN |
2GPO | A:235-458 | ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A SYNTHETIC PEPTIDE FROM RIP140 |
2GPP | A:233-457; B:233-456 | ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A RIP140 PEPTIDE AND SYNTHETIC LIGAND GSK4716 |
2GPU | A:234-455 | ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN |
2GPV | A:232-455; B:233-455; C:233-455; D:233-441; E:234-441; F:233-440 | ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE |
2GTK | A:207-477 | STRUCTURE-BASED DESIGN OF INDOLE PROPIONIC ACIDS AS NOVEL PPARAG CO-AGONISTS |
2GWX | A:211-476; B:211-477 | MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS |
2H77 | A:152-406 | CRYSTAL STRUCTURE OF HUMAN TR ALPHA BOUND T3 IN MONOCLINIC SPACE GROUP |
2H79 | A:142-408 | CRYSTAL STRUCTURE OF HUMAN TR ALPHA BOUND T3 IN ORTHORHOMBIC SPACE GROUP |
2HAM | A:119-423 | CRYSTAL STRUCTURE OF VDR LBD COMPLEXED TO 2ALPHA-PROPYL-CALCITRIOL |
2HAR | A:119-423 | CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2 ALPHA-(3-HYDROXY-1-PROPOXY) CALCITRIOL |
2HAS | A:119-423 | CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA-(1-PROPOXY) CALCITRIOL |
2HB7 | A:119-423 | CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA(3-HYDROXY-1-PROPYL) CALCITRIOL |
2HB8 | A:119-423 | CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA-METHYL CALCITRIOL |
2HFP | A:206-477 | CRYSTAL STRUCTURE OF PPAR GAMMA WITH N-SULFONYL-2-INDOLE CARBOXAMIDE LIGANDS |
2HVC | A:669-918 | THE CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN (LBD) OF HUMAN ANDROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE MODULATOR LGD2226 |
2HWQ | B:207-467; A:207-477 | STRUCTURAL BASIS FOR THE STRUCTURE-ACTIVITY RELATIONSHIPS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS |
2HWR | B:207-467; A:207-477 | STRUCTURAL BASIS FOR THE STRUCTURE-ACTIVITY RELATIONSHIPS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS |
2I0G | B:260-498; A:261-498 | BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA |
2I0J | B:306-547; D:306-547; C:306-528; A:306-528 | BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA |
2I4J | A:207-476; B:207-476 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE AGONIST LT160 (UREIDOFIBRATE DERIVATIVE) |
2I4P | A:207-476; B:207-476 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE PARTIAL AGONIST LT127 (UREIDOFIBRATE DERIVATIVE). STRUCTURE OBTAINED FROM CRYSTALS OF THE APO-FORM SOAKED FOR 30 DAYS. |
2I4Z | A:207-476; B:207-476 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE PARTIAL AGONIST LT127 (UREIDOFIBRATE DERIVATIVE). THIS STRUCTURE HAS BEEN OBTAINED FROM CRYSTALS SOAKED FOR 6 HOURS. |
2IOG | A:309-551 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 11F |
2IOK | B:1306-1544; A:306-544 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 1D |
2J14 | B:175-439; A:174-440 | 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2 |
2J4A | A:211-461 | HUMAN THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH KB131084 |
2JF9 | A:305-528; C:305-529; B:305-529 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST |
2JFA | A:305-529; B:306-528 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE |
2JJ3 | B:260-501; A:261-499 | ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST |
2LBD | A:182-419 | LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID |
2NPA | C:199-468; A:199-467 | THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID |
2NV7 | A:263-500; B:263-497 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555 |
2O9I | A:142-433; B:1142-1433 | CRYSTAL STRUCTURE OF THE HUMAN PREGNANE X RECEPTOR LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND T0901317 |
2OAX | F:738-982; D:738-982; E:738-982; A:738-982; B:739-982; C:738-982 | CRYSTAL STRUCTURE OF THE S810L MUTANT MINERALOCORTICOID RECEPTOR ASSOCIATED WITH SC9420 |
2OCF | A:305-548 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH ESTRADIOL AND THE E2#23 FN3 MONOBODY |
2OM9 | B:207-476; D:207-476; A:207-476; C:207-476 | AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA |
2OUZ | A:306-551 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA-LASOFOXIFENE COMPLEX |
2OVH | A:681-932 | PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO-REPRESSOR SMRT |
2OVM | A:682-932 | PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO-REPRESSOR NCOR |
2OZ7 | A:671-919 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR T877A MUTANT LIGAND-BINDING DOMAIN WITH CYPROTERONE ACETATE |
2P15 | A:305-549; B:306-550 | CRYSTAL STRUCTURE OF THE ER ALPHA LIGAND BINDING DOMAIN WITH THE AGONIST ORTHO-TRIFLUOROMETHYLPHENYLVINYL ESTRADIOL |
2P1T | A:229-458 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-METHOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 |
2P1U | A:229-458 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-ETHOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 |
2P1V | A:229-458 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-PROPOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 |
2P4Y | A:205-477; B:209-477 | CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA-LIGAND BINDING DOMAIN COMPLEXED WITH AN INDOLE-BASED MODULATOR |
2P54 | A:202-468 | A CRYSTAL STRUCTURE OF PPAR ALPHA BOUND WITH SRC1 PEPTIDE AND GW735 |
2P7A | A:234-456 | CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH 3-METHYL PHENOL |
2P7G | A:235-456 | X-RAY STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH BISPHENOL A. |
2P7Z | A:235-441 | ESTROGEN RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXY-TAMOXIFEN |
2PIN | A:210-460; B:211-460 | THYROID RECEPTOR BETA IN COMPLEX WITH INHIBITOR |
2PIO | A:671-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PIP | L:670-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PIQ | A:670-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PIR | A:669-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PIT | A:669-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PIU | A:671-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PIV | A:670-918 | ANDROGEN RECEPTOR WITH SMALL MOLECULE |
2PIW | A:671-918 | ANDROGEN RECEPTOR WITH SMALL MOLECULE |
2PIX | A:671-918 | AR LBD WITH SMALL MOLECULE |
2PJL | A:282-517; B:282-517 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA IN COMPLEX WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS NOVEL MOLECULAR MECHANISM |
2PKL | A:670-918 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
2PNU | A:670-919 | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH EM-5744 |
2POB | B:206-474; A:207-475 | PPARGAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A FARGLITAZAR ANALOGUE GW4709 |
2POG | A:306-550; B:306-528 | BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR B AGONISTS (SERBAS). PART 2: STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON THE BENZOPYRAN SCAFFOLD. |
2PRG | B:207-477; A:207-477 | LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA |
2Q59 | B:207-475; A:207-475 | CRYSTAL STRUCTURE OF PPARGAMMA LBD BOUND TO FULL AGONIST MRL20 |
2Q5G | B:209-459; A:210-474 | LIGAND BINDING DOMAIN OF PPAR DELTA RECEPTOR IN COMPLEX WITH A PARTIAL AGONIST |
2Q5P | B:207-475; A:207-476 | CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST MRL24 |
2Q5S | A:208-477; B:207-476 | CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST NTZDPA |
2Q61 | A:209-477; B:207-476 | CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN BOUND TO PARTIAL AGONIST SR145 |
2Q6J | A:306-549; B:305-548 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED TO A B-N SUBSTITUTED LIGAND |
2Q6R | A:207-476; B:207-477 | CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED WITH PARTIAL AGONIST SF147 |
2Q6S | B:207-475; A:207-474 | 2.4 ANGSTROM CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED TO BVT.13 WITHOUT CO-ACTIVATOR PEPTIDES |
2Q70 | A:306-549; B:306-528 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLXED TO A BENZOPYRAN LIGAND |
2Q7I | A:671-919 | THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE |
2Q7J | A:671-919 | THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX 3 COACTIVATOR PEPTIDE 740-753 |
2Q7K | A:671-919 | THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE |
2Q7L | A:671-919 | THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX3 COACTIVATOR PEPTIDE 740-753 |
2Q8S | A:207-474; B:207-475 | X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST |
2QA6 | B:306-550; A:305-549 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA MUTANT 537S COMPLEXED WITH 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL |
2QA8 | B:305-549; A:305-548 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH GENISTEIN |
2QAB | A:305-548; B:305-549 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH AN ETHYL INDAZOLE COMPOUND |
2QE4 | A:306-528; B:306-528 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST |
2QGT | B:305-548; A:305-548 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO AN ETHER ESTRADIOL COMPOUND |
2QGW | A:305-548; B:305-549 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH A CHLORO-INDAZOLE COMPOUND |
2QH6 | A:304-548; B:305-547 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DIARYLETHYLENE COMPOUND |
2QNV | A:142-434 | CRYSTAL STRUCTURE OF THE PREGNANE X RECEPTOR BOUND TO COLUPULONE |
2QR9 | A:305-549; B:306-550 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DERIVATIVE COMPOUND |
2QSE | A:305-549; B:306-550 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH BURNED MEAT COMPOUND 4-OH-PHIP |
2QTU | B:260-500; A:261-498 | ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND |
2QW4 | A:32-264; B:32-264; C:30-264; D:32-265 | HUMAN NR4A1 LIGAND-BINDING DOMAIN |
2QXM | B:306-550; A:305-549 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO BURNED MEAT COMPOUND PHIP |
2QXS | A:306-547; B:306-548 | CRYSTAL STRUCTURE OF ANTAGONIZING MUTANT 536S OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO RALOXIFENE |
2QZO | B:306-549; A:305-549 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH WAY-169916 |
2R6W | A:306-549; B:306-546 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO A SERM |
2R6Y | A:306-549; B:306-545 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SERM |
2REW | A:199-467 | CRYSTAL STRUCTURE OF PPARALPHA LIGAND BINDING DOMAIN WITH BMS-631707 |
2VSR | B:207-474; A:207-475 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S)-HODE |
2VST | B:207-474; A:204-475 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S)-HODE |
2VV0 | B:208-476; A:203-475 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH DHA |
2VV1 | A:206-475; B:209-473 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-HDHA |
2VV2 | A:207-474; B:207-474 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5-HEPA |
2VV3 | B:207-474; A:207-475 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-OXODHA |
2VV4 | A:205-475; B:206-474 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXOOTE |
2W8Y | A:683-933; B:683-933 | RU486 BOUND TO THE PROGESTERONE RECEPTOR IN A DESTABILIZED AGONISTIC CONFORMATION |
2Z4B | B:260-500; A:261-498 | ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND |
2Z4J | A:671-918 | CRYSTAL STRUCTURE OF AR LBD WITH SHP PEPTIDE NR BOX 2 |
2ZAS | A:232-458 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH 4-ALPHA-CUMYLPHENOL, A BISPHENOL A DERIVATIVE |
2ZBS | A:232-459 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN APO FORM |
2ZKC | A:232-459 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL Z |
3B3K | A:207-476; B:207-476 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE FULL AGONIST LT175 |
3B5R | A:671-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-31 |
3B65 | A:671-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-24 |
3B66 | A:671-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-21 |
3B67 | A:671-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-23 |
3B68 | A:671-917 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-4 |
3BEJ | B:244-471; A:245-471 | STRUCTURE OF HUMAN FXR IN COMPLEX WITH MFA-1 AND CO-ACTIVATOR PEPTIDE |
3BQD | A:525-777 | DOUBLING THE SIZE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING POCKET BY DEACYLCORTIVAZOL |
3CJW | A:171-407 | CRYSTAL STRUCTURE OF THE HUMAN COUP-TFII LIGAND BINDING DOMAIN |
3CLD | B:528-776; A:526-776 | LIGAND BINDING DOMAIN OF THE GLUCOCORTICOID RECEPTOR COMPLEXED WITH FLUTICAZONE FUROATE |
3CS4 | A:119-423 | STRUCTURE-BASED DESIGN OF A SUPERAGONIST LIGAND FOR THE VITAMIN D NUCLEAR RECEPTOR |
3CS6 | A:119-423 | STRUCTURE-BASED DESIGN OF A SUPERAGONIST LIGAND FOR THE VITAMIN D NUCLEAR RECEPTOR |
3CWD | A:208-477; B:208-476 | MOLECULAR RECOGNITION OF NITRO-FATTY ACIDS BY PPAR GAMMA |
3D57 | A:210-460; B:211-460 | TR VARIANT D355R |
3D5F | A:211-476; B:211-477 | CRYSTAL STRUCTURE OF PPAR-DELTA COMPLEX |
3D90 | A:682-931; B:683-932 | CRYSTAL STRUCTURE OF THE HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN BOUND TO LEVONORGESTREL |
3DCT | A:244-472 | FXR WITH SRC1 AND GW4064 |
3DCU | A:244-472 | FXR WITH SRC1 AND GSK8062 |
3DT3 | B:306-548; A:306-551 | HUMAN ESTROGEN RECEPTOR ALPHA LBD WITH GW368 |
3DY6 | B:210-475; A:208-475 | PPARDELTA COMPLEXED WITH AN ANTHRANILIC ACID PARTIAL AGONIST |
3E7C | B:525-776; A:526-776 | GLUCOCORTICOID RECEPTOR LBD BOUND TO GSK866 |
3ERD | B:305-550; A:305-550 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
3ERT | A:306-552 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN |
3FAL | B:202-443; D:202-443 | HUMANRXR ALPHA & MOUSE LXR ALPHA COMPLEXED WITH RETENOIC ACID AND GSK2186 |
3FC6 | B:203-443; D:203-443 | HRXRALPHA & MLXRALPHA WITH AN INDOLE PHARMACOPHORE, SB786875 |
3FLI | A:248-475 | DISCOVERY OF XL335, A HIGHLY POTENT, SELECTIVE AND ORALLY-ACTIVE AGONIST OF THE FARNESOID X RECEPTOR (FXR) |
3FS1 | A:139-368 | CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR PGC-1A FRAGMENT |
3FXV | A:247-475 | IDENTIFICATION OF AN N-OXIDE PYRIDINE GW4064 ANALOGUE AS A POTENT FXR AGONIST |
3G8O | A:682-932; B:683-932 | PROGESTERONE RECEPTOR WITH BOUND PYRROLIDINE 1 |
3GD2 | A:244-472 | ISOXAZOLE LIGAND BOUND TO FARNESOID X RECEPTOR (FXR) |
3GN8 | A:-2-246; B:-2-246 | X-RAY CRYSTAL STRUCTURE OF ANCGR2 IN COMPLEX WITH DEXAMETHASONE |
3GWS | X:202-460 | CRYSTAL STRUCTURE OF T3-BOUND THYROID HORMONE RECEPTOR |
3GWX | A:207-477; B:207-477 | MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS |
3H0A | A:228-455 | CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) AND RETINOIC ACID RECEPTOR ALPHA (RXRA) IN COMPLEX WITH 9-CIS RETINOIC ACID, CO-ACTIVATOR PEPTIDE, AND A PARTIAL AGONIST |
3HC5 | A:244-472 | FXR WITH SRC1 AND GSK826 |
3HC6 | A:243-472 | FXR WITH SRC1 AND GSK088 |
3HLV | A:304-548; B:304-548 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND 16-ALPHA-HYDROXY-ESTRONE ((8S,9R,13S,14R, 16R)-3,16-DIHYDROXY-13-METHYL-7,8,9,11,12,14,15, 16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE |
3HM1 | B:303-550; A:306-548 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTRONE ((8R,9S,13S,14S)-3-HYDROXY-13-METHYL-7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE) |
3HZF | A:145-407 | STRUCTURE OF TR-ALFA BOUND TO SELECTIVE THYROMIMETIC GC-1 IN C2 SPACE GROUP |
3ILZ | A:144-410 | STRUCTURE OF TR-ALFA BOUND TO SELECTIVE THYROMIMETIC GC-1 IN P212121 SPACE GROUP |
3IMY | A:201-461 | STRUCTURE OF TR-BETA BOUND TO SELECTIVE THYROMIMETIC GC-1 |
3IPQ | A:205-445 | X-RAY STRUCTURE OF GW3965 SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA |
3IPS | B:205-446; A:205-446 | X-RAY STRUCTURE OF BENZISOXAZOLE SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA |
3IPU | A:204-445; B:205-445 | X-RAY STRUCTURE OF BENZISOXAZOLE UREA SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA |
3JZB | A:144-407 | CRYSTAL STRUCTURE OF TR-ALFA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC |
3JZC | A:202-460 | CRYSTAL STRUCTURE OF TR-BETA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC |
3KFC | C:220-439 | COMPLEX STRUCTURE OF LXR WITH AN AGONIST |
3KMR | A:182-415 | CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH AN AGONIST LIGAND (AM580) AND A COACTIVATOR FRAGMENT |
3KMZ | A:181-401; B:181-401 | CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH THE INVERSE AGONIST BMS493 AND A COREPRESSOR FRAGMENT |
3L1B | A:245-475 | COMPLEX STRUCTURE OF FXR LIGAND-BINDING DOMAIN WITH A TETRAHYDROAZEPINOINDOLE COMPOUND |
3LBD | A:182-418 | LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO 9-CIS RETINOIC ACID |
3PRG | A:200-477 | LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR |
4LBD | A:182-418 | LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS961 |
4PRG | A:207-476; B:207-476; C:207-476; D:207-476 | 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL |